BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 2
• 3
• 4
• 5
• 6
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30
• 31

• Pharm Country

  Progenics: Unloved And Undervalued ~$5 Biotech Stock

  October 2, 2017

   · 

  1 min read
• Policy

  Court Upholds Boston Scientific’s Win Over Stent Pioneer Dr. David Jang

  October 2, 2017

   · 

  1 min read
• Pharm Country

  Pfizer Exposes The Sordid Underbelly Of Drug Prices

  October 2, 2017

   · 

  1 min read
• BioMidwest

  The Long-Term Trend That Makes Intuitive Surgical An Awesome Buy

  October 2, 2017

   · 

  1 min read
• Deals

  Why Abbott’s Torturous Alere Deal Drama Isn’t Over Yet

  October 2, 2017

   · 

  1 min read
• Policy

  Biotech Founded By Pharma Bro Shkreli Escapes $43 Million Lawsuit

  U.S. District Judge Edgardo Ramos in Manhattan said Vyera was liable for the money under its contract with Impax, but did not have to pay it because Impax had violated the contract as well.

  October 2, 2017

   · 

  1 min read
• This U.S. Marijuana Stock Is Arguably The Best On The Market—And It’s Dirt Cheap

  October 2, 2017

   · 

  1 min read
• Biotech Beach

  The Small SoCal Biotech Big Pharma Has Thrown Hundreds Of Million Of Dollars At

  October 2, 2017

   · 

  1 min read
• 

  Policy

  Iconic Cher Sues NantHealth’s Soon-Shiong Over Altor BioScience Stock Fraud

  October 2, 2017

   · 

  2 min read
• 

  Pharm Country

  Boy Wonder Ramaswamy’s Roivant Bets $116 Million on Arbutus

  October 2, 2017

   · 

  2 min read